Opthea Limited Logo

Opthea Limited

OPT.AX

(1.2)
Stock Price

0,66 AUD

-129.38% ROA

398.06% ROE

-1.43x PER

Market Cap.

723.739.295,41 AUD

-186.85% DER

0% Yield

-138376.57% NPM

Opthea Limited Stock Analysis

Opthea Limited Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Opthea Limited Fundamental Stock Analysis
# Analysis Rating
1 PBV

With a remarkably low PBV ratio (-14.71x), the stock offers substantial upside potential at a bargain price.

2 DER

The stock has a minimal amount of debt (-3%) relative to its ownership, showcasing a strong financial position and lower risk for investors.

3 Graham Number

The company's Graham number indicates that it is undervalued compared to its stock price, suggesting a potentially favorable investment opportunity.

4 ROE

Negative ROE (-675.16%) indicates poor financial performance, raising concerns about profitability and efficiency in utilizing shareholders' equity.

5 ROA

The stock's ROA (-144.48%) suggests that it's struggling to generate profits from its assets, making it a risky choice for investment.

6 Revenue Growth

Regrettably, this company's revenue has shown no signs of growth over the past three years, suggesting limited potential for returns and making it a less appealing choice.

7 Net Profit Growth

This company's net profit has remained stagnant over the past five years, indicating a lack of growth and making it a less favorable investment option.

8 Assets Growth

Company's revenue has stayed stagnant, showing no signs of improvement and making it a less favorable choice.

9 Dividend Growth

The company's dividend growth has remained unchanged for three years, signaling a lack of positive momentum and making it a less favorable investment choice.

10 Dividend

The company has not distributed any dividends in the past three years, which may raise concerns for investors looking for regular income from their investments.

11 Buffet Intrinsic Value

The company's stock shows signs of being overvalued (0) according to Warren Buffett's formula, indicating a potential downside as its market price exceeds its estimated intrinsic value.

Opthea Limited Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Opthea Limited Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Buy
3 RSI Hold
4 Stoch RSI Hold

Opthea Limited Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Opthea Limited Revenue
Year Revenue Growth
1989 0
1990 0 0%
1991 0 0%
1992 0 0%
1993 0 0%
1994 0 0%
1995 0 0%
1996 0 0%
1997 240.510 100%
1998 192.735 -24.79%
1999 2.938.822.648 99.99%
2000 0 0%
2001 0 0%
2002 9.571 100%
2003 0 0%
2004 12.235 100%
2005 13.343 8.3%
2006 0 0%
2007 19.129 100%
2008 14.351 -33.29%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 112.497 100%
2020 0 0%
2020 145.899 100%
2021 91.981 -58.62%
2022 125.047 26.44%
2023 161.163 22.41%
2024 372.724 56.76%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Opthea Limited Research and Development Expenses
Year Research and Development Expenses Growth
1989 0
1990 0 0%
1991 7.669 100%
1992 0 0%
1993 0 0%
1994 0 0%
1995 0 0%
1996 0 0%
1997 0 0%
1998 600.339 100%
1999 358.333 -67.54%
2000 186.153 -92.49%
2001 553.000 66.34%
2002 144.690 -282.2%
2003 106.500 -35.86%
2004 349.778 69.55%
2005 533.751 34.47%
2006 1.201.366 55.57%
2007 2.674.405 55.08%
2008 3.271.367 18.25%
2009 3.618.360 9.59%
2010 3.650.477 0.88%
2011 7.021.882 48.01%
2012 3.679.797 -90.82%
2013 3.136.296 -17.33%
2014 3.401.685 7.8%
2015 4.284.228 20.6%
2016 3.581.295 -19.63%
2017 4.838.300 25.98%
2018 24.891.534 80.56%
2019 31.347.891 20.6%
2020 17.954.073 -74.6%
2020 17.480.747 -2.71%
2021 34.710.152 49.64%
2022 108.459.978 68%
2023 181.563.523 40.26%
2024 518.601.928 64.99%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Opthea Limited General and Administrative Expenses
Year General and Administrative Expenses Growth
1989 0
1990 0 0%
1991 59.818 100%
1992 43.325 -38.07%
1993 74.815 42.09%
1994 113.258 33.94%
1995 132.097 14.26%
1996 204.750 35.48%
1997 252.308 18.85%
1998 0 0%
1999 332.208 100%
2000 320.838 -3.54%
2001 1.880.000 82.93%
2002 1.161.468 -61.86%
2003 1.322.733 12.19%
2004 1.341.584 1.41%
2005 1.648.591 18.62%
2006 2.039.456 19.17%
2007 3.394.988 39.93%
2008 3.438.888 1.28%
2009 3.766.971 8.71%
2010 4.567.863 17.53%
2011 4.364.805 -4.65%
2012 3.584.464 -21.77%
2013 3.109.225 -15.28%
2014 2.652.041 -17.24%
2015 2.361.587 -12.3%
2016 2.863.441 17.53%
2017 3.250.164 11.9%
2018 2.699.847 -20.38%
2019 5.087.508 46.93%
2020 3.937.485 -29.21%
2020 6.609.639 40.43%
2021 11.878.179 44.35%
2022 16.304.959 27.15%
2023 19.270.494 15.39%
2024 53.110.292 63.72%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Opthea Limited EBITDA
Year EBITDA Growth
1989 -511.891
1990 -627.419 18.41%
1991 -163.350 -284.1%
1992 -72.459 -125.44%
1993 -348.027 79.18%
1994 -78.916 -341.02%
1995 -521.999 84.88%
1996 -967.051 46.02%
1997 240.510 502.08%
1998 192.735 -24.79%
1999 2.938.822.648 99.99%
2000 -534.339 550093.2%
2001 -807.295 33.81%
2002 -3.216.417 74.9%
2003 -2.941.634 -9.34%
2004 -1.783.908 -64.9%
2005 17.634.379 110.12%
2006 -3.907.416 551.31%
2007 -37.876.643 89.68%
2008 -12.626.437 -199.98%
2009 -7.574.400 -66.7%
2010 -10.171.625 25.53%
2011 -11.196.543 9.15%
2012 -8.918.896 -25.54%
2013 -7.223.530 -23.47%
2014 -6.256.098 -15.46%
2015 -6.973.374 10.29%
2016 -8.054.169 13.42%
2017 -9.869.260 18.39%
2018 -29.880.480 66.97%
2019 -36.635.591 18.44%
2020 -24.918.383 -47.02%
2020 -24.678.649 -0.97%
2021 -53.036.420 53.47%
2022 -133.162.000 60.17%
2023 -223.298.770 40.37%
2024 -575.211.200 61.18%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Opthea Limited Gross Profit
Year Gross Profit Growth
1989 0
1990 0 0%
1991 0 0%
1992 0 0%
1993 0 0%
1994 0 0%
1995 0 0%
1996 0 0%
1997 240.510 100%
1998 192.735 -24.79%
1999 2.938.822.648 99.99%
2000 -27.346 10746909.95%
2001 0 0%
2002 9.571 100%
2003 0 0%
2004 12.235 100%
2005 13.343 8.3%
2006 0 0%
2007 19.129 100%
2008 14.351 -33.29%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 -30.791 100%
2017 -26.614 -15.69%
2018 -28.655 7.12%
2019 -161.446 82.25%
2020 0 0%
2020 -371.365 100%
2021 -480.001 22.63%
2022 -107.422 -346.84%
2023 -89.309 -20.28%
2024 59.192 250.88%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Opthea Limited Net Profit
Year Net Profit Growth
1989 -410.721
1990 -492.576 16.62%
1991 -138.809 -254.86%
1992 -60.507 -129.41%
1993 -341.347 82.27%
1994 -45.303 -653.48%
1995 -472.284 90.41%
1996 -857.588 44.93%
1997 -1.053.626 18.61%
1998 -1.229.823 14.33%
1999 1.582.301.886 100.08%
2000 730.417 -216529.94%
2001 -801.172 191.17%
2002 -3.233.870 75.23%
2003 -2.362.860 -36.86%
2004 4.056.890 158.24%
2005 16.599.333 75.56%
2006 -4.802.887 445.61%
2007 9.502.444 150.54%
2008 -1.098.157 965.31%
2009 -8.003.235 86.28%
2010 -5.905.103 -35.53%
2011 -10.971.235 46.18%
2012 -4.950.420 -121.62%
2013 -4.339.225 -14.09%
2014 -3.762.350 -15.33%
2015 -4.074.368 7.66%
2016 -6.507.420 37.39%
2017 -6.192.896 -5.08%
2018 -16.902.240 63.36%
2019 -20.910.061 19.17%
2020 -16.529.281 -26.5%
2020 -16.117.515 -2.55%
2021 -60.788.020 73.49%
2022 -127.990.214 52.51%
2023 -211.880.680 39.59%
2024 -589.669.292 64.07%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Opthea Limited Earning per Share (EPS)
Year Earning per Share (EPS) Growth
1989 0
1990 0 0%
1991 0 0%
1992 0 0%
1993 0 0%
1994 0 0%
1995 0 0%
1996 0 0%
1997 0 0%
1998 0 0%
1999 49 100%
2000 0 0%
2001 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2024 -1 100%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Opthea Limited Free Cashflow
Year Free Cashflow Growth
1989 0
1990 0 0%
1991 -197.000 100%
1992 -267.000 26.22%
1993 -351.000 23.93%
1994 -477.038 26.42%
1995 -676.261 29.46%
1996 -1.222.875 44.7%
1997 -1.785.912 31.53%
1998 -72.154 -2375.14%
1999 -12.460.000 99.42%
2000 -14.650 -84957%
2001 -1.031.150 98.58%
2002 -1.053.330 2.11%
2003 -15.113 -6870.15%
2004 -1.713.046 99.12%
2005 -1.643.260 -4.25%
2006 -2.900.347 43.34%
2007 32.915.506 108.81%
2008 -1.828.958 1899.69%
2009 -6.601.107 72.29%
2010 -7.562.583 12.71%
2011 -9.497.729 20.37%
2012 -7.213.302 -31.67%
2013 -5.615.724 -28.45%
2014 -4.285.430 -31.04%
2015 -5.026.656 14.75%
2016 -3.692.961 -36.11%
2017 -6.048.515 38.94%
2018 -19.971.967 69.71%
2019 -24.203.226 17.48%
2020 -8.247.926 -193.45%
2020 -1.810 -455838.42%
2021 -61.075.405 100%
2022 -98.390.418 37.93%
2023 -179.336.531 45.14%
2024 -106.310.452 -68.69%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Opthea Limited Operating Cashflow
Year Operating Cashflow Growth
1989 0
1990 0 0%
1991 -197.000 100%
1992 -267.000 26.22%
1993 -351.000 23.93%
1994 -469.000 25.16%
1995 -672.000 30.21%
1996 -1.215.000 44.69%
1997 -1.740.962 30.21%
1998 0 0%
1999 0 0%
2000 0 0%
2001 -1.005.125 100%
2002 -1.040.944 3.44%
2003 0 0%
2004 -1.708.946 100%
2005 -1.636.369 -4.44%
2006 -2.888.112 43.34%
2007 32.971.572 108.76%
2008 -1.798.092 1933.7%
2009 -6.589.155 72.71%
2010 -7.542.908 12.64%
2011 -9.415.565 19.89%
2012 -7.173.904 -31.25%
2013 -5.612.996 -27.81%
2014 -4.174.307 -34.47%
2015 -5.026.656 16.96%
2016 -3.681.236 -36.55%
2017 -6.045.438 39.11%
2018 -19.937.550 69.68%
2019 -24.185.156 17.56%
2020 -8.244.259 -193.36%
2020 0 0%
2021 -61.058.377 100%
2022 -98.367.101 37.93%
2023 -179.303.893 45.14%
2024 -106.303.929 -68.67%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Opthea Limited Capital Expenditure
Year Capital Expenditure Growth
1989 0
1990 0 0%
1991 0 0%
1992 0 0%
1993 0 0%
1994 8.038 100%
1995 4.261 -88.62%
1996 7.875 45.89%
1997 44.950 82.48%
1998 72.154 37.7%
1999 12.460.000 99.42%
2000 14.650 -84957%
2001 26.025 43.71%
2002 12.386 -110.13%
2003 15.113 18.05%
2004 4.100 -268.68%
2005 6.891 40.51%
2006 12.235 43.68%
2007 56.065 78.18%
2008 30.866 -81.65%
2009 11.952 -158.26%
2010 19.675 39.26%
2011 82.164 76.05%
2012 39.398 -108.55%
2013 2.728 -1344.7%
2014 111.123 97.55%
2015 0 0%
2016 11.725 100%
2017 3.077 -281.05%
2018 34.417 91.06%
2019 18.070 -90.46%
2020 3.667 -392.77%
2020 1.810 -102.71%
2021 17.028 89.38%
2022 23.317 26.97%
2023 32.638 28.56%
2024 6.523 -400.43%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Opthea Limited Equity
Year Equity Growth
1989 2.446.206
1990 1.505.488 -62.49%
1991 1.316.768 -14.33%
1992 1.647.879 20.09%
1993 1.626.575 -1.31%
1994 2.099.302 22.52%
1995 2.074.500 -1.2%
1996 3.834.341 45.9%
1997 5.323.536 27.97%
1998 4.329.192 -22.97%
1999 7.155.912 39.5%
2000 14.999.211 52.29%
2001 24.200.486 38.02%
2002 23.278.910 -3.96%
2003 24.514.307 5.04%
2004 29.151.402 15.91%
2005 28.628.365 -1.83%
2006 42.067.181 31.95%
2007 51.709.674 18.65%
2008 49.183.812 -5.14%
2009 31.291.941 -57.18%
2010 27.042.955 -15.71%
2011 23.324.896 -15.94%
2012 20.669.356 -12.85%
2013 13.103.977 -57.73%
2014 9.866.171 -32.82%
2015 16.660.488 40.78%
2016 14.978.154 -11.23%
2017 54.491.964 72.51%
2018 38.172.446 -42.75%
2019 31.119.537 -22.66%
2020 64.808.137 51.98%
2021 180.200.823 64.04%
2022 69.769.714 -158.28%
2023 -8.793.176 893.45%
2024 -75.810.077 88.4%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Opthea Limited Assets
Year Assets Growth
1989 2.445.451
1990 1.530.871 -59.74%
1991 1.322.136 -15.79%
1992 1.668.795 20.77%
1993 1.637.263 -1.93%
1994 2.125.607 22.97%
1995 2.142.679 0.8%
1996 3.929.628 45.47%
1997 5.490.803 28.43%
1998 4.491.130 -22.26%
1999 7.298.018 38.46%
2000 15.217.297 52.04%
2001 24.366.334 37.55%
2002 23.487.782 -3.74%
2003 24.832.562 5.42%
2004 29.463.740 15.72%
2005 32.917.452 10.49%
2006 43.787.020 24.82%
2007 56.707.955 22.79%
2008 51.523.231 -10.06%
2009 33.314.363 -54.66%
2010 29.463.662 -13.07%
2011 26.187.287 -12.51%
2012 23.133.833 -13.2%
2013 14.977.558 -54.46%
2014 11.732.288 -27.66%
2015 18.463.893 36.46%
2016 17.052.600 -8.28%
2017 56.544.667 69.84%
2018 46.075.854 -22.72%
2019 37.660.462 -22.35%
2020 71.887.198 47.61%
2021 184.361.196 61.01%
2022 87.321.775 -111.13%
2023 148.187.965 41.07%
2024 188.791.216 21.51%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Opthea Limited Liabilities
Year Liabilities Growth
1989 34.730
1990 25.382 -36.83%
1991 29.142 12.9%
1992 38.843 24.97%
1993 21.375 -81.72%
1994 32.150 33.51%
1995 68.889 53.33%
1996 95.287 27.7%
1997 167.267 43.03%
1998 161.938 -3.29%
1999 142.106 -13.96%
2000 218.085 34.84%
2001 165.847 -31.5%
2002 208.872 20.6%
2003 318.255 34.37%
2004 312.337 -1.89%
2005 4.289.086 92.72%
2006 1.719.838 -149.39%
2007 4.998.280 65.59%
2008 2.339.418 -113.65%
2009 2.022.421 -15.67%
2010 2.420.706 16.45%
2011 2.862.390 15.43%
2012 2.464.476 -16.15%
2013 1.873.580 -31.54%
2014 1.866.116 -0.4%
2015 1.803.404 -3.48%
2016 2.074.446 13.07%
2017 2.052.703 -1.06%
2018 7.903.408 74.03%
2019 6.540.925 -20.83%
2020 7.079.061 7.6%
2021 4.160.372 -70.15%
2022 17.552.061 76.3%
2023 156.981.141 88.82%
2024 264.601.293 40.67%

Opthea Limited Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0
Net Income per Share
-0.41
Price to Earning Ratio
-1.43x
Price To Sales Ratio
4100.09x
POCF Ratio
-1.92
PFCF Ratio
-3.99
Price to Book Ratio
-4.6
EV to Sales
3925.47
EV Over EBITDA
-2.78
EV to Operating CashFlow
-3.82
EV to FreeCashFlow
-3.82
Earnings Yield
-0.7
FreeCashFlow Yield
-0.25
Market Cap
0,72 Bil.
Enterprise Value
0,69 Bil.
Graham Number
1.09
Graham NetNet
-0.14

Income Statement Metrics

Net Income per Share
-0.41
Income Quality
0.74
ROE
3.98
Return On Assets
-1.29
Return On Capital Employed
-2
Net Income per EBT
0.95
EBT Per Ebit
1.03
Ebit per Revenue
-1413.43
Effective Tax Rate
0.05

Margins

Sales, General, & Administrative to Revenue
186.98
Research & Developement to Revenue
1243.47
Stock Based Compensation to Revenue
39.4
Gross Profit Margin
-0.17
Operating Profit Margin
-1413.43
Pretax Profit Margin
-1460.06
Net Profit Margin
-1383.77

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
-0.31
Free CashFlow per Share
-0.31
Capex to Operating CashFlow
-0
Capex to Revenue
0.16
Capex to Depreciation
0.2
Return on Invested Capital
-3.59
Return on Tangible Assets
-1.29
Days Sales Outstanding
24450.31
Days Payables Outstanding
67335.1
Days of Inventory on Hand
0
Receivables Turnover
0.01
Payables Turnover
0.01
Inventory Turnover
0
Capex per Share
0

Balance Sheet

Cash per Share
0,29
Book Value per Share
-0,13
Tangible Book Value per Share
-0.13
Shareholders Equity per Share
-0.13
Interest Debt per Share
0.29
Debt to Equity
-1.87
Debt to Assets
0.75
Net Debt to EBITDA
0.12
Current Ratio
2.94
Tangible Asset Value
-0,08 Bil.
Net Current Asset Value
-0,08 Bil.
Invested Capital
124268857
Working Capital
0,12 Bil.
Intangibles to Total Assets
0
Average Receivables
0,01 Bil.
Average Payables
0,03 Bil.
Average Inventory
-807712.5
Debt to Market Cap
0.2

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Opthea Limited Dividends
Year Dividends Growth
2004 0

Opthea Limited Profile

About Opthea Limited

Opthea Limited, a clinical stage biopharmaceutical company, develops and commercializes therapies primarily for eye disease in Australia. The company's development activities are based on the intellectual property portfolio covering Vascular Endothelial Growth Factors (VEGF) VEGF-C, VEGF-D, and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage. Its lead asset is OPT 302, a soluble form of VEGFR 3 in clinical development as a novel therapy for wet neovascular age related macular degeneration and diabetic macular edema (DME), as well as a first in class VEGF-C/D inhibitors for treatment with VEGF-A inhibitors to treat wet neovascular AMD and other retinal diseases. The company was formerly known as Circadian Technologies Limited and changed its name to Opthea Limited in December 2015. Opthea Limited was incorporated in 1984 and is based in South Yarra, Australia.

CEO
Dr. Frederic Guerard M.S., Ph
Employee
33
Address
650 Chapel Street
South Yarra, 3141

Opthea Limited Executives & BODs

Opthea Limited Executives & BODs
# Name Age
1 Dr. Fang Li Ph.D.
Senior Vice President of Regulatory Affairs
70
2 Ms. Karen Adams CPA
Vice President of Finance & Company Secretary
70
3 Mr. Kevin Bitter
Vice President of Strategy & Corporate Development
70
4 Ms. Sarika Gulhar Ph.D.
Executive Director of Human Resources
70
5 Dr. Michael Gerometta Ph.D.
Head of Chemistry, Manufacturing & Controls Development
70
6 Dr. Kenneth Sall
Chief Medical Officer
70
7 Mr. Daniel E. Geffken M.B.A.
Interim Chief Financial Officer
70
8 Dr. Julie Clark M.D., M.S.
Senior Vice President of Clinical Development
70
9 Dr. Frederic Guerard M.S., Pharm.D.
Chief Executive Officer
70
10 Dr. Megan Baldwin M.A.I.C.D., MAICD, Ph.D.
Founder, Chief Innovation Officer & Executive Director
70

Opthea Limited Competitors